BIIB vs PKE · P/E 21, rev $9.89B vs P/E 51, rev $73.3M
Biogen Inc (BIIB) versus Park Electrochemical Corporation (PKE) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Park Electrochemical Corporation (PKE) is a aerospace & defense company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported PKE revenue for 2026-03-01 was $73.3M. Net income was $11.3M. Revenue was up 18.2% from 2025-03-02 to 2026-03-01. PKE currently screens at market cap $291.2M and trailing P/E 50.6.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. PKE currently screens at market cap $291.2M and trailing P/E 50.6.
Not investment advice. Open the BIIB and PKE stock pages for the full models.
Not investment advice.